We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Tibiopedal Access for Crossing of Infrainguinal Artery Occlusions

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01609621
Recruitment Status : Completed
First Posted : June 1, 2012
Last Update Posted : December 20, 2016
Sponsor:
Information provided by (Responsible Party):

Study Description
Brief Summary:
The objective of this prospective, non-randomized, multicenter, post-market, observational study is to compile clinical data on percutaneous techniques used to obtain tibiopedal access and to cross infrainguinal arterial occlusions.

Condition or disease Intervention/treatment
Peripheral Arterial Disease Critical Limb Ischemia Device: Retrograde tibiopedal arterial access

Study Design

Study Type : Observational
Actual Enrollment : 199 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Tibiopedal Access for Crossing of Infrainguinal Artery Occlusions
Study Start Date : May 2012
Primary Completion Date : July 2013
Study Completion Date : August 2013
Groups and Cohorts

Group/Cohort Intervention/treatment
Retrograde access Device: Retrograde tibiopedal arterial access
Retrograde, percutaneous arterial access of vessels at or below the tibioperoneal trunk, using a 21 gage needle or micropuncture introducer set, to facilitate crossing and treatment (e.g., angioplasty, stenting, atherectomy) of occlusive arterial lesions in the lower limb.


Outcome Measures

Primary Outcome Measures :
  1. Technical Success deeming tibial pedal arterial access [ Time Frame: 1 - 4 hours post-procedure. ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients will be selected among those presenting with symptoms of peripheral arterial ischemic disease of the lower extremities and for whom endovascular intervention is deemed appropriate.
Criteria

Inclusion Criteria:

  • Patient has a totally occluded infrainguinal artery, due to peripheral arterial atherosclerotic disease, for which a previous attempt to cross the occlusion using an antegrade approach was unsuccessful. For institutions where tibiopedal access is performed as a primary standard-of-care procedure, a prior unsuccessful antegrade approach attempt is not required.

Exclusion Criteria:

  • Patient will not sign the Informed Consent
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01609621


Locations
United States, Arizona
Interventional Technologies, LLC (Tucson Medical Center)
Tucson, Arizona, United States, 85712
United States, District of Columbia
MedStar Health Research Institute (Washington Hospital Center)
Washington, District of Columbia, United States, 20010
United States, Florida
First Coast Cardiovascular Institute
Jacksonville, Florida, United States, 32216
University of Miami (Mount Sinai Hospital)
Miami, Florida, United States, 33140
United States, Louisiana
Terrebone Medical Center
Houma, Louisiana, United States, 70360
United States, Michigan
Metro Heart and Vascular
Wyoming, Michigan, United States, 49519
United States, North Carolina
Rex Hospital, Inc
Raleigh, North Carolina, United States, 27607
United States, West Virginia
CAMC Health Education and Research Institute, Inc.
Charleston, West Virginia, United States, 25304
Germany
Universit ts-Herzzentrum Freiburg - Bad Krozingen GmbH
Bad Krozingen, Germany, 79189
Park-Krankenhaus Leipzig GmbH
Leipzig, Germany, 04289
Italy
Casa Di Cura Abano Terme
Abano Herme, Italy, 35031
Sponsors and Collaborators
Cook Group Incorporated
Investigators
Principal Investigator: Craig Walker, MD Terrebone General Medical Center
More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Cook Group Incorporated
ClinicalTrials.gov Identifier: NCT01609621     History of Changes
Other Study ID Numbers: 11-008
First Posted: June 1, 2012    Key Record Dates
Last Update Posted: December 20, 2016
Last Verified: December 2016

Additional relevant MeSH terms:
Ischemia
Peripheral Arterial Disease
Peripheral Vascular Diseases
Pathologic Processes
Atherosclerosis
Arteriosclerosis
Arterial Occlusive Diseases
Vascular Diseases
Cardiovascular Diseases